Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Rectal Neoplasms × 30 days × Clear all

Phase

Phase NA 16 Phase 2 14 Phase 1 6 Phase 3 4 Phase 1/2 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Myasthenia Gravis 4 Lung Neoplasms 4 Urinary Bladder Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myeloid, Acute 3 Fallopian Tube Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Melanoma 2 Liposarcoma 2 Leukemia, Myelomonocytic, Chronic 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Ulcer 1

Interventions

Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03051464 2026-02-17

Morpheus

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2/3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡